±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 579  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

hljmmj

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] °ïæ·­ÒëÕªÒª7ÐÐ,Íò·Ö¸Ðл

Key results: Pre-incubation of neutrophils with montelukast resulted in dose-related inhibition of the generation of reactive oxygen species and leukotriene B4 by chemoattractant-activated neutrophils, as well as release of elastase, all of which were maximal at 2 mmol¡¤L-1 (mean percentages of the control values of 30  1, 12  3 and 21  3 respectively; P < 0.05). From a mechanistic perspective, treatment of chemoattractant-activated neutrophils with montelukast resulted in significant reduc-
tions in both post-peak cytosolic Ca2+ concentrations and store-operated Ca2+ influx. These montelukast-mediated alterations in Ca2+ handling by the cells were associated with a significant elevation in basal cAMP levels, which resulted from inhibition of cyclic nucleotide phosphodiesterases.
Conclusions and implications: Montelukast, primarily a cysteinyl leukotriene (CysLT1) receptor antagonist, exhibited previously undocumented, secondary, neutrophil-directed anti-inflammatory properties, which appeared to be cAMP-dependent.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baoshanqiu

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
hljmmj: ½ð±Ò+10, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2016-01-04 09:01:20
Ö÷Òª½á¹û£º½«ÖÐÐÔÁ£Ï¸°ûÓëÃÏÂ³Ë¾ÌØÔ¤ÅàÑøµ¼Ö¼ÁÁ¿Ïà¹ØµØÒÖÖÆ»¯Ñ§Ç÷»¯¼Á¼¤»îÖÐÐÔÁ£Ï¸°û»îÐÔÑõ´ØºÍ°×ÈýÏ©B4µÄ²úÉú¼°µ¯ÐÔµ°°×øµÄÊÍ·Å£¬ËùÓÐÖµ¾ùÔÚ2 mmol¡¤L-1´ï¸ß·å£¨¶ÔÕÕÖµµÄƽ¾ù°Ù·ÖÂÊ·Ö±ðΪ 30.1, 12.3 ºÍ 21.3; P < 0.05)¡£´Ó»úÀíÉÏ¿´£¬»¯Ñ§Ç÷»¯¼Á¼¤»îµÄÖÐÐÔÁ£Ï¸°û¾­ÃÏÂ³Ë¹ÌØ´¦Àíµ¼Ö·åºóϸ°ûÖʸÆÀë×ÓŨ¶ÈºÍ¸Æ³Øµ÷¿Ø¸ÆÀë×ÓÄÚÁ÷¾ùÏÔÖø¼õÉÙ¡£ÕâЩÓÉÃÏÂ³Ë¾ÌØ½éµ¼µÄϸ°û¶Ô¸ÆÀë×Ó´¦ÀíÄÜÁ¦µÄ¸Ä±äÓë»·ºËÜÕËáÁ×Ëá¶þõ¥Ã¸ÒÖÖÆÒýÆðcAMP»ù´¡Ë®Æ½ÏÔÖøÉý¸ßÓйء£
½áÂÛ¼°º¬Ò⣺Ê×ÏÈ£¬ÃÏÂ³Ë¾ÌØ×÷Ϊ°ëë×°±õ£°×ÈýÏ© (CysLT1)ÊÜÌåÞ׿¹¼ÁÏÈǰδÓб¨µÀ£¬Æä´Î£¬¶ÔÖÐÐÔÁ£Ï¸°ûµÄ¿¹Ñ×Ö¢ÌØÐÔ±íÏÖΪ cAMPÒÀÀµÐÔ¡£
2Â¥2015-12-31 01:40:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ hljmmj µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼Á +8 JLLLLLLLLLL 2026-04-03 8/400 2026-04-03 22:06 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 311Çóµ÷¼Á +11 Ó¸ҵÄСÎâ 2026-04-02 11/550 2026-04-03 21:46 by qlm5820
[¿¼ÑÐ] ²ÄÁÏ334Çóµ÷¼Á +9 Eecho# 2026-04-03 9/450 2026-04-03 21:38 by lbsjt
[¿¼ÑÐ] ¹¤¿Æ 267Çóµ÷¼Á +5 wanwan00 2026-04-02 7/350 2026-04-03 14:14 by zhangdingwa
[¿¼ÑÐ] 266Çóµ÷¼Á +3 08µçÆø¹¤³Ì 2026-04-03 3/150 2026-04-03 14:05 by 1753564080
[¿¼ÑÐ] 282Çóµ÷¼Á +5 ºôÎü¶¼ÊǼõ·Ê 2026-03-31 5/250 2026-04-03 12:03 by 1753564080
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤´óѧ£¬080500ѧ˶£¬317·Ö£¬Çóµ÷¼Á +13 s1145 2026-03-31 15/750 2026-04-03 11:44 by msi123
[»ù½ðÉêÇë] ÇëÎʹ²Í¬Í¨Ñ¶ºÍ¹²Í¬Ò»×÷µÄÈϿɶÈÎÊÌâ 10+4 psa1234 2026-04-01 10/500 2026-04-03 11:08 by Kittylucky
[¿¼ÑÐ] 085600 295·ÖÇóµ÷¼Á +19 W55j 2026-03-30 23/1150 2026-04-03 09:53 by ǧǧÔËÆø
[¿¼ÑÐ] 312Çóµ÷¼Á +6 ССī123 2026-04-02 7/350 2026-04-03 07:32 by jsw79
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 285Çóµ÷¼Á +14 AZMK 2026-04-02 14/700 2026-04-02 15:54 by ÉϾÅÌìÀ¿Ô£¨ºÃÔ
[¿¼²©] ²ÄÁϹ¤³Ìרҵ˶ʿÉ격 +3 ÷ëÕýÓî 2026-03-30 3/150 2026-04-02 15:04 by greychen00
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó²ÄÁϹ¤³Ì290Çóµ÷¼Á +20 Youth_ 2026-03-30 20/1000 2026-04-02 14:48 by 5896
[¿¼ÑÐ] 085900ÍÁľˮÀû336·ÖÇóµ÷¼Á +4 Zhangjiangj 2026-03-31 6/300 2026-04-02 11:40 by 1753564080
[¿¼ÑÐ] 0805Çóµ÷¼Á +8 ÊÇË®·Ö 2026-03-31 8/400 2026-04-02 10:46 by guanxin1001
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 09:52 by yulian1987
[¿¼ÑÐ] 085600 Ò»Ö¾Ô¸9 ×Ü·Ö351 Çóµ÷¼ÁѧУ +7 czhcz 2026-03-31 9/450 2026-04-01 19:24 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 335Çóµ÷¼Á +3 321* 2026-03-31 4/200 2026-04-01 00:00 by 321*
[¿¼ÑÐ] 296Çóµ÷¼Á +10 ±Ë°¶t 2026-03-29 10/500 2026-03-30 10:50 by ̽123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û